Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmpeak Energy Regulatory News (AMP)

Share Price Information for Ampeak Energy (AMP)

Share Price is delayed by 15 minutes
Get Live Data
2.70    0.00 (0.00%)
Bid:
2.60
Ask:
2.80
Spread: 0.20 (7.692%)
Market Cap: £19.52m
AMP Live PriceLast checked at - London Stock Exchange

Intraday Ampeak Energy Share Chart

IP Licensing

24 Sep 2010 07:00

RNS Number : 2356T
Amphion Innovations PLC
24 September 2010
 

Amphion Innovations plc

IP Licensing

 

London and New York, 24 September 2010 - Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of medical and technology businesses, today announces that its wholly owned subsidiary, DataTern, Inc., has settled certain pending patent infringement litigation over its U.S. Patents 6,101,502 and 5,937,402, generating total revenues of $500,000.

 

DataTern has signed 22 licenses of these patents since June 2008, generating total revenues of approximately $14 million. DataTern has now licensed its intellectual property into the financial, credit card, retail, leisure, healthcare, airline, e-commerce, and software industries.

 

DataTern, Inc., was originally established in order to commercialise selected intellectual property opportunities in partnership with Amphion's Partner Companies. As part of the licensing programme described above, DataTern offers to license all parties in all industries under these patents.

 

For further information please contact:

Amphion Innovations plc Charlie Morgan +44 779 953 6043

 

Cardew Group Tim Robertson/ Jamie Milton +44 20 7930 0777

 

Charles Stanley (Nominated Adviser) Mark Taylor +44 20 7149 6000

 

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 8 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number that grows rapidly each year.

 

On the web: www.amphionplc.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUOABRRKAKUAR
Date   Source Headline
1st Jul 201312:02 pmRNSDirector/PDMR Shareholding
28th Jun 20137:00 amRNSFinal Results
18th Apr 20137:00 amRNSDirector/PDMR Shareholding
17th Apr 20137:00 amRNSTrading Statement
28th Mar 20137:02 amRNSChange of Adviser
19th Dec 20127:00 amRNSHolding(s) in Company
13th Dec 20127:00 amRNSFundraising
5th Dec 20127:00 amRNSAmphion announces new partnership with Motif
3rd Oct 20127:00 amRNSDirector/PDMR Shareholding
28th Sep 20124:24 pmRNSDirector/PDMR Shareholding
19th Sep 20127:00 amRNSHalf Yearly Report
29th Aug 20127:00 amRNSUpdate - patent litigation
27th Jul 20127:00 amRNSResult of AGM
23rd Jul 20127:00 amRNSDirectors Dealings
20th Jul 201212:00 pmRNSFunding Update
20th Jul 20127:00 amRNSTrading Statement
11th Jun 20127:00 amRNSFinal Results
9th May 20129:20 amRNSFunding update
1st May 20127:00 amRNSPartner Company Update
28th Mar 20127:00 amRNSPartner Company Update
28th Feb 20127:00 amRNSDirector Dealings
23rd Feb 20124:36 pmRNSFunding Update
3rd Feb 20123:24 pmRNSFunding Update
2nd Feb 20127:00 amRNSPatent Approval
30th Dec 20117:00 amRNSDirector Dealings
6th Dec 20119:09 amRNSDirector/PDMR Shareholding
21st Nov 20118:42 amRNSNew Suits Filed and New Debt Facilites
29th Sep 20117:00 amRNSHalf Yearly Report
21st Sep 20117:00 amRNSNotice of Results
9th Sep 20117:00 amRNSIssue of Equity
2nd Aug 20117:00 amRNSTrading Statement
28th Jul 20117:00 amRNSAdjournment of AGM
22nd Jul 20118:20 amRNSDirector/PDMR Shareholding
21st Jul 20119:03 amRNSDirector/PDMR Shareholding
30th Jun 20117:00 amRNSFinal Results
21st Jun 20114:44 pmRNSNew Debt Facility
24th May 20117:00 amRNSDisposal
15th Apr 20119:19 amRNSNew debt facility
14th Apr 20117:00 amRNSNotice of Results
13th Apr 20117:00 amRNSUpdate on Data Tern Patent Litigation
30th Mar 20117:00 amRNSIP Licences and Directorate Change
28th Feb 20117:00 amRNSTrading Statement
6th Jan 20117:00 amRNSChange of Adviser
5th Jan 20117:00 amRNSIP License Agreements
9th Dec 20107:00 amRNSNew Debt Facility
25th Oct 20107:00 amRNSPartner Update
18th Oct 20103:50 pmRNSDirector/PDMR Shareholding
30th Sep 20104:19 pmRNSTotal Voting Rights
24th Sep 20107:00 amRNSIP Licensing
22nd Sep 20108:00 amRNSGrant Win by Partner Company Firestar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.